https://www.selleckchem.com/products/e-7386.html
Improving screening in these high-risk groups has the potential to substantially reduce the burden of CRC.Introduction Although coronavirus disease (COVID-19) has been associated with gastrointestinal manifestations, its effect on the pancreas remains unclear. We aimed to assess the frequency and characteristics of hyperlipasemia in patients with COVID-19. Methods A retrospective cohort study of hospitalized patients across 6 US centers with COVID-19. Results Of 71 patients, 9 (12.1%) developed hyperlipasemia, with 2 (2.8%) greater than
Like
Comment
Share
